These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17088654)

  • 21. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD; Larsen JN
    Immunol Allergy Clin North Am; 2006 May; 26(2):191-206, v-vi. PubMed ID: 16701140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinically relevant major cross-reactive allergen from mesquite tree pollen.
    Dhyani A; Singh BP; Arora N; Jain VK; Sridhara S
    Eur J Clin Invest; 2008 Oct; 38(10):774-81. PubMed ID: 18837803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardization of allergen extracts.
    Aas K
    Dev Biol Stand; 1975; 29():341-51. PubMed ID: 1149939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Purification and standardization of allergens].
    Guérin B
    Rev Med Suisse Romande; 1994 Mar; 114(3):251-4. PubMed ID: 8171235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CREATE project: a new beginning of allergen standardization based on mass units of major allergens.
    van Ree R
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):70-3; discussion 74-5. PubMed ID: 15119023
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein families: implications for allergen nomenclature, standardisation and specific immunotherapy.
    Breiteneder H
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():249-54; discussion 254-6. PubMed ID: 20799468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
    Cox L; Jacobsen L
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myrmecia pilosula (Jack Jumper) ant venom: validation of a procedure to standardise an allergy vaccine.
    Wiese MD; Milne RW; Davies NW; Chataway TK; Brown SG; Heddle RJ
    J Pharm Biomed Anal; 2008 Jan; 46(1):58-65. PubMed ID: 17933477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of Art v 1 and Act c 1 being major allergens of mugwort pollen and kiwi fruit extracts in mass-units by ion-exchange HPLC-UV method.
    Blanusa M; Perovic I; Popovic M; Polovic N; Burazer L; Milovanovic M; Gavrovic-Jankulovic M; Jankov R; Cirkovic Velickovic T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):188-94. PubMed ID: 17652037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines.
    Chapman MD; Ferreira F; Villalba M; Cromwell O; Bryan D; Becker WM; Fernández-Rivas M; Durham S; Vieths S; van Ree R;
    J Allergy Clin Immunol; 2008 Nov; 122(5):882-889.e2. PubMed ID: 18762328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compliance and acceptance problems with standardized extracts.
    Lehrer SB
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):211-7. PubMed ID: 7873061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardization of Allergen Extracts.
    Larsen JN; Dreborg S
    Methods Mol Biol; 2019; 2020():63-76. PubMed ID: 31177492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of allergen extracts.
    Slater JE
    Dev Biol (Basel); 2005; 122():145-52. PubMed ID: 16375259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of allergen standardization.
    Jeong KY; Hong CS; Lee JS; Park JW
    Yonsei Med J; 2011 May; 52(3):393-400. PubMed ID: 21488181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergen standardization: CREATE principles applied to other purified allergens.
    Chapman MD; Filep S; Tsay A; Vailes LD; Gadermaier G; Ferreira F; King EM
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():21-4; discussion 25. PubMed ID: 20799442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.